Hemin‐induced platelet activation is regulated by the ACKR3 chemokine surface receptor and has implications for passivation of vulnerable atherosclerotic plaques
2024

Hemin and Platelet Activation: The Role of ACKR3

publication 10 minutes Evidence: high

Author Information

Author(s): Z. Laspa, V. Dicenta-Baunach, D. Schaale, M. Sigle, R. Hochuli, T. Castor, A. Bayrak, T. Harm, K. A. L. Müller, T. Pillaiyar, S. Laufer, A. K. Rohlfing, M. P. Gawaz

Primary Institution: University Hospital Tübingen

Hypothesis

Does ACKR3 agonism inhibit hemin-induced platelet activation?

Conclusion

Hemin activates platelets and promotes thrombus formation, but ACKR3 agonism can inhibit these effects.

Supporting Evidence

  • Hemin induces platelet aggregation and thrombus formation.
  • ACKR3 agonists significantly decrease hemin-induced platelet activation.
  • Hemin enhances ACKR3 surface expression on platelets.
  • ACKR3 agonism preserves platelet integrity in the presence of hemin.
  • Hemin promotes the formation of procoagulant platelet subpopulations.

Takeaway

Hemin can make platelets very active, which can lead to blood clots, but a special receptor called ACKR3 can help calm them down.

Methodology

The study used multi-color flow cytometry and light transmission aggregometry to analyze platelet activation and thrombus formation.

Limitations

The study's findings may not fully translate to in vivo situations due to the rapid inhibition of hemin by plasma proteins.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1111/febs.17294

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication